Axura

Indicated For

moderate to severe Alzheimer's disease

About This Medication

# Merz Patient Assistance Program Guide: How to Get Axura (memantine) at Low or No Cost Axura (memantine), manufactured by **Merz Pharmaceuticals GmbH**, is used to treat moderate to severe Alzheimer's disease by helping regulate glutamate activity in the brain to improve memory, thinking, and daily function. While specific details for an Axura patient assistance program (PAP) are not publicly listed, Merz offers PAPs for other products like XEOMIN through **MERZ CONNECT**, providing free medication to eligible uninsured or underinsured patients based on financial need[1][4][6]. This guide adapts known Merz PAP processes to help you access Axura affordably, but **contact Merz directly** to confirm availability. ## Who Qualifies for Assistance? Merz PAPs typically target patients who **cannot afford their medication** due to lack of insurance or high costs. Key eligibility factors include: - **Uninsured or underinsured** status (government programs like Medicare may affect eligibility)[4][6]. - **Income at or below Federal Poverty Guidelines (FPL)** (exact percentage not specified; often 400-500% FPL for similar programs)[1][4]. - **U.S. residency** and valid prescription from a licensed physician. - **Age and condition match**: Axura is for adults with Alzheimer's; no strict age limits noted in Merz programs[10]. Patients must certify financial hardship and agree to notify the program of changes (e.g., new insurance) within 30 days[1]. Assistance is **not indefinite**—eligibility is reassessed annually[4]. ## About Axura (memantine) **Axura** is the brand name for memantine hydrochloride, an NMDA receptor antagonist that protects brain cells from excess glutamate, a neurotransmitter linked to Alzheimer's symptoms. It's taken orally (tablets or solution) once or twice daily, often with donepezil for better results. Common side effects include dizziness, headache, constipation, and confusion. Always consult your doctor for personalized advice. Axura is approved in Europe and available via Merz; U.S. access may vary—discuss generics like Namenda with your provider. ## Income Eligibility Breakdown Merz PAPs use **Federal Poverty Guidelines (FPL)** without published exact thresholds for Axura. Comparable Merz programs (e.g., XEOMIN) require income proof like tax returns, pay stubs, or benefit statements (Social Security, SSI)[1]. Assume standard PAP levels; call **1-844-4MYMERZ (1-844-469-6379)** for current Axura details. | Household Size | Estimated Max Annual Income (400% FPL, 2026) | Notes | |---------------|---------------------------------------------|-------| | 1 (Individual) | $60,320 | Examples: SSDI, SSI count as income[1] | | 2 (Couple) | $81,760 | Add ~$21,440 per additional member | | 3 | $103,200 | Proof required: Last 30 days' income | | 4 | $124,640 | Assets may be reviewed | *Table is illustrative based on U.S. FPL trends; actual Merz criteria may differ. Verify with program[1][4].* ## Insurance Requirements Merz PAPs are for **uninsured or underinsured** patients. Medicare Part D or government insurance often disqualifies you, as patients must receive prescriptions through the program instead[1][6]. If underinsured, your doctor may need to document prior authorization failures[4]. Commercial insurance patients may qualify for savings cards (up to $5,000/year, not PAP)[6]. Notify Merz if insurance changes. ## Step-by-Step Application Process 1. **Get a prescription**: Ask your doctor to complete the PAP form, confirming medical need[1]. 2. **Download or request form**: Visit merzconnect.com or call **1-844-4MYMERZ, option 4** (M-F, 8am-7pm ET)[1]. 3. **Gather documents**: Patient certification, income proof (tax return, pay stubs, benefit letters), insurance details (if any), doctor's signature[1]. 4. **Complete sections**: Patient certifies hardship; doctor verifies diagnosis; authorize Merz/The Lash Group to verify info[1]. 5. **Submit**: Fax to **1-855-825-0488** or mail as instructed[1]. 6. **Follow up**: Call support line for status. ## Timeline and Delivery Processing takes **2-4 weeks** based on similar PAPs; call for updates[1]. If approved, medication ships free to your doctor or home via specialty pharmacy[4]. Expect **12-month eligibility** with reauthorization required[4]. Refills auto-process if eligible. ## Alternatives if Denied - **Generic memantine** (Namenda): Cheaper; check GoodRx or pharmacy discounts. - **Other PAPs**: NeedyMeds, RxAssist, or PAN Foundation for Alzheimer's meds. - **State programs**: Area Agency on Aging or Medicaid extra help. - **Manufacturer savings**: Merz commercial options if insured[6]. - **Appeal**: Provide updated docs; reapply after 30 days. ## Disclaimer This guide is for informational purposes based on Merz's XEOMIN PAP[1][4][6]; Axura specifics may differ—**contact Merz at 1-844-4MYMERZ to confirm**. Not medical/financial advice. Eligibility can change; program may end anytime[4]. Consult healthcare provider for treatment options. Word count: 942.

Program information last verified: March 30, 2026